CHITOGEN INC

PLYMOUTH, MN · CIK 0001470264 · Medtech · Private

Chitosan fiber hemostatic pad for accelerating blood clot formation

chitogen.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$347K
5 Form D · Dec 2023
34 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$105,000
Private capital raisedForm D · SEC$35,000
Private capital raisedForm D · SEC$207,000
Private capital raisedForm D · SEC$750,000
Private capital raisedForm D · SEC$1,050,000
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
983ICHOR VASCULAR INC.—$3.1M
984SPEECHVIVE, INC.—$280K
985VIVAQUANT, LLC—$175K
986CHITOGEN INC—$347K
987Happy Cloud, Inc.—$4.5M
988ISOMARK, LLC—$262K
989Plasmology4, Inc.—$5.5M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 11 related persons
  • Frederick AlbrightDirector
  • James DrakeDirector · Executive Officer
  • Douglas EayrsDirector · Executive Officer
  • Albert EmolaDirector · Executive Officer
  • Kai KrollDirector · Executive Officer
  • Robert LevyDirector
  • Steve MuellerleileExecutive Officer
  • Michael ReillyDirector · Executive Officer
  • Thomas RitterExecutive Officer
  • Donald SturtevantDirector
  • Yong ZhuDirector

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.